v3.26.1
Basis of Presentation
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation

 

2. Basis of Presentation

 

Statement of compliance

 

These condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The accompanying condensed consolidated financial statements are unaudited and have been prepared pursuant to the rules and regulations of the SEC regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended December 31, 2025, included in the Company’s 2025 Annual Report. The policies set out below have been consistently applied to all periods presented unless otherwise noted.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal and recurring adjustments, except as otherwise indicated) considered necessary to present fairly, in all material respects, the Company’s financial position as of March 31, 2026, its results of operations for the three months ended March 31, 2026 and 2025, and its cash flows for the three months ended March 31, 2026 and 2025. Interim results are not necessarily indicative of the results that may be expected for any other interim period or for the full fiscal year.

 

These condensed consolidated financial statements were approved and authorized for issuance by the Company’s Board of Directors on May 6, 2026.

 

Liquidity and going concern

 

Historically, the Company’s primary source of liquidity has been its operations, capital contributions made by equity investors and debt issuances. The Company is currently meeting its current operational obligations as they become due from its current working capital and from operations. However, the Company has sustained losses since inception and may require additional capital in the future. As of and for the three months ended March 31, 2026, the Company had an accumulated deficit of $139,803,363, a net loss and comprehensive loss attributable to the Company of $426,253, and net cash provided by operating activities of $395,001.  Such uncertainties related to events and conditions raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company is generating cash from revenues and deploying its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and near term. Capital reserves are primarily being utilized for capital expenditures, facility improvements, product development and marketing.

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations associated with financial liabilities. The Company manages liquidity risk through the management of its capital structure. The Company’s approach to managing liquidity is to ensure that it will have sufficient liquidity to settle obligations and liabilities when due.

 

Basis of presentation and measurement

 

These consolidated financial statements have been prepared on a historical cost basis except for derivative financial instruments, which are measured at fair value through earnings, as explained in the accounting policies below. Historical costs are generally based upon the fair value of the consideration given in exchange for goods and services. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date.

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no material effect on the consolidated results of operations, stockholders’ deficit, or cash flows.

 

Functional currency

 

All figures presented in the consolidated financial statements are reflected in United States dollars; however, the functional currency of the Company includes Canadian dollars and United States dollars. The Company’s subsidiaries functional currency is the United States dollar.

 

Transactions in foreign currencies are initially recorded in the Company’s functional currency at the exchange rate at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the functional currency rate of exchange at the end of each reporting period. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates as at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when fair value is determined.

 

All gains and losses on translation of these foreign currency transactions are included in earnings.

 

 

On consolidation, the assets and liabilities of foreign operations reported in their functional currencies are translated into United States dollars, the Company’s presentation currency, at period-end exchange rates. Income and expenses, and cash flows of foreign operations are translated into United States dollars using average exchange rates. Exchange differences resulting from translating foreign operations are recognized in accumulated other comprehensive loss.

 

Basis of consolidation

 

These consolidated financial statements as of March 31, 2026 and December 31, 2025 include the accounts of the Company, its wholly-owned subsidiaries. Subsidiaries are entities controlled by the Company. Control exists when the Company has the power, directly and indirectly, to govern the financial and operating policies of an entity and be exposed to the variable returns from its activities. The financial statements of subsidiaries are included in the audited annual financial statements from the date that control commences until the date that control ceases.

 

The following is a list of the Company’s wholly-owned and partially owned operating subsidiaries:

 

Name of Consolidated Subsidiary or Entity  Purpose  Jurisdiction 

Attributable

Interest

 
Aya Biosciences, Inc.  Pharmaceutical  US   100%
Anderson Development SB, LLC.  Cultivation  US   100%
Paleo Paw Corp.  CBD Wellness  US   100%
Payne Distribution, LLC.  Distribution  US   100%
LEEF Brands, Inc.  Holding Company  Canada   100%
LEEF Holdings, Inc.  Holding Company  US   100%
Preferred Brand LLC.  Manufacturing  US   100%
Seven Zero Seven, LLC.  Manufacturing  US   100%
LEEF Management, LLC.  Payroll  US   100%
1127466 B.C. Ltd.  Real Estate  Canada   100%
1200665 B.C. Ltd.  Real Estate  Canada   100%
SCRSB, LLC.  Cultivation  US   100%
The Leaf at 73740, LLC.  Dispensary  US   100%
Green Cross Nevada LLC.  Manufacturing  US   100%
V6E Holdings, LLC.  Manufacturing  US   100%
LEEF Labs NY LLC.  Manufacturing  US   100%
LEEF Labs NJ, LLC.  Manufacturing  US   100%
Eaton Processing LLC  Manufacturing  US   100%

 

All inter-company transactions and balances have been eliminated in the consolidated financial statement presentation.